Bio-equivalence
Bio-equivalence is defined as the observation and finding similarities of one or more drugs. Formulations involve the same active substance or element are called bio-equivalence. If their rate of absorption and formulations are identical, they are pronounced to be bioequivalence drugs. The United States food and Drug Administration (FDA) has explained bio-equivalence as "the absence of a significant difference in the rate and range to which the active ingredient or active subdivision in pharmaceutical equivalents or pharmaceutical substitute becomes available at the site of drug action when administered at the same molar dose below similar conditions in an appropriately designed study.
- Rate Of immersion
- Expression of Medicines
Related Conference of Bio-equivalence
7th International Conference on Clinical Pharmacology and Toxicology
Bio-equivalence Conference Speakers
Recommended Sessions
- Behavior toxicology
- Bio-availability
- Bio-equivalence
- Biochemical Pharmacology
- Biologic drugs
- Clinical and medical pharmacology
- Drug discovery and Drug development
- Drug Safety
- Environmental Toxicology
- Genotoxicity
- Microbial Toxicology
- Molecular Pharmacology
- Nanomedicine and Nanotechnology
- Pharmaceutical biotechnology
- Pharmacodynamics
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology and Toxicology
- Pharmacovigilance
- Route of administration
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)